NeuroDerm Ltd (NDRM)-医療機器分野:企業M&A・提携分析

◆英語タイトル:NeuroDerm Ltd (NDRM) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011523
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
NeuroDerm Ltd (NeuroDerm) is a clinical stage pharmaceutical company that focuses on the development of drugs for the treatment of Parkinson’s disease and central nervous system (CNS) disorders through proprietary reformulations of its existing drugs. The company’s levodopa/carbidopa (LD/CD) product candidates include ND0612L, intended for moderate Parkinson’s diseases and ND0612H, for severe Parkinson’s disease. It also develops ND0701, intended for patients with severe Parkinson’s disease and ND0801, a product candidate intended for the treatment of cognitive disorders associated with CNS diseases including attention deficit disorder/attention deficit hyperactivity disorder, alzheimer’s disease, and other diseases. NeuroDerm is headquartered in Rehovot, Israel.

NeuroDerm Ltd (NDRM) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
NeuroDerm Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
NeuroDerm Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
NeuroDerm Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
NeuroDerm Ltd, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
NeuroDerm Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
NeuroDerm Ltd, Medical Equipment, Deal Details 10
Venture Financing 10
NeuroDerm Raises USD16 Million in Venture Financing 10
Equity Offering 11
NeuroDerm Completes Underwriters Exercise of Over-Allotment Option of Public Offering for USD86.3 Million 11
NeuroDerm Raises USD77 Million in Public Offering of Shares 13
NeuroDerm Raises USD45 Million in IPO 15
NeuroDerm Ltd – Key Competitors 17
NeuroDerm Ltd – Key Employees 18
NeuroDerm Ltd – Locations And Subsidiaries 19
Head Office 19
Recent Developments 20
Financial Announcements 20
Aug 03, 2017: NeuroDerm Announces Second Quarter 2017 Financial Results 20
May 11, 2017: NeuroDerm Announces First Quarter 2017 Financial Results 21
Mar 30, 2017: NeuroDerm Announces Fourth Quarter and Full Year 2016 Financial Results 23
Nov 10, 2016: NeuroDerm Announces Third Quarter 2016 Financial Results 25
Aug 25, 2016: NeuroDerm Announces Second Quarter 2016 Financial Results and Provides Corporate Update 27
May 26, 2016: NeuroDerm Announces First Quarter 2016 Financial Results 29
Mar 31, 2016: NeuroDerm Announces Fourth Quarter and Full Year 2015 Financial Results and Provides a Corporate Update 30
Corporate Communications 32
Jul 06, 2016: NeuroDerm Announces Additions to Management Team 32
Product News 33
Dec 02, 2016: NeuroDerm Announces Top-Line Results of Pilot PK Trial Comparing ND0701 with Commercial Apomorphine 33
Jul 27, 2016: NeuroDerm Announces Issuance of a New U.S. Patent for Aqueous Apomorphine Covering Concentrated Subcutaneously Delivered Pharmaceutical Compositions 34
Jul 26, 2016: NeuroDerm Announces Start of Bioequivalence Trial in Healthy Volunteers of ND0701 35
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36

List of Tables
NeuroDerm Ltd, Medical Equipment, Key Facts, 2016 2
NeuroDerm Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
NeuroDerm Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
NeuroDerm Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
NeuroDerm Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
NeuroDerm Ltd, Deals By Market, 2011 to YTD 2017 8
NeuroDerm Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
NeuroDerm Raises USD16 Million in Venture Financing 10
NeuroDerm Completes Underwriters Exercise of Over-Allotment Option of Public Offering for USD86.3 Million 11
NeuroDerm Raises USD77 Million in Public Offering of Shares 13
NeuroDerm Raises USD45 Million in IPO 15
NeuroDerm Ltd, Key Competitors 17
NeuroDerm Ltd, Key Employees 18

★海外企業調査レポート[NeuroDerm Ltd (NDRM)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Promimic AB:医療機器:M&Aディール及び事業提携情報
    Summary Promimic AB (Promimic) is a biomaterial company that develops and markets nano-thin surface modifications for all implant materials and geometries. The company offers thin HA surface modification for orthopedic and dental implants, which improves osseointegration and bone healing around inte …
  • Rollprint Packaging Products Inc.:企業の戦略・SWOT・財務情報
    Rollprint Packaging Products Inc. - Strategy, SWOT and Corporate Finance Report Summary Rollprint Packaging Products Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Trina Solar Ltd:電力:M&Aディール及び事業提携情報
    Summary Trina Solar Ltd (Trina Solar) is a vertically-integrated solar power products manufacturer. The company manufactures a wide variety of PV modules, both monocrystalline and multicrystalline; ingots, wafers, cells and solar modules. The company also designs, constructs, sells and operates sola …
  • Sirenas LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Sirenas LLC (Sirenas), formerly Sirenas Marine Discovery LLC, is a biotechnology company that discovers therapeutics derived from nature's chemistry. The company’s proprietary data mining technologyATLANTIS uses data mining and machine learningapproach to uncover the therapeutic potential of …
  • Strata Oncology Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Strata Oncology Inc (Strata Oncology) is a precision oncology company. The company offers tumor sequencing to advanced cancer patients and a portfolio of biomarker-matched precision medicine trials. It identifies patients to design and conduct transformative precision oncology trials to acce …
  • Antibe Therapeutics Inc (ATE):製薬・医療:M&Aディール及び事業提携情報
    Summary Antibe Therapeutics Inc (Antibe) is a biotech company that designs and develops drug candidates for chronic pain and inflammation; and regenerative medicine. The company discovers and commercializes novel drugs, biologics and medical devices. It offers lead compound ATB-346, a naproxen deriv …
  • Hanwha Techwin Co Ltd:企業の戦略・SWOT・財務情報
    Hanwha Techwin Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Hanwha Techwin Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Mexan Limited:企業の戦略・SWOT・財務分析
    Mexan Limited - Strategy, SWOT and Corporate Finance Report Summary Mexan Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Circassia Pharmaceuticals Plc (CIR):製薬・医療:M&Aディール及び事業提携情報
    Summary Circassia Pharmaceuticals plc (Circassia) develops and manufactures drugs for the treatment of allergy and respiratory diseases such as asthma. The company’s marketed products include Niox used to assist asthma management and Tudorza for the treatment of chronic obstructive pulmonary disease …
  • Quest Diagnostics Incorporated:企業の戦略・SWOT・財務情報
    Quest Diagnostics Incorporated - Strategy, SWOT and Corporate Finance Report Summary Quest Diagnostics Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • FUDAN University-製薬・医療分野:企業M&A・提携分析
    Summary FUDAN University (FUDAN) is an educational university that offers bachelor, undergraduate, master and doctoral degrees in various disciplines. The university confers bachelor's degrees in multiple academic disciplines. It conducts research in various disciplines such as natural sciences, dep …
  • Eagle Insurance Ltd:企業の戦略・SWOT・財務分析
    Eagle Insurance Ltd - Strategy, SWOT and Corporate Finance Report Summary Eagle Insurance Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Blueberry Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Blueberry Therapeutics Ltd (Blueberry Therapeutics) is a provider of nano medicines for the treatment of dermatological disorders. Its pipeline product portfolio includes BB2603-NCE, developed to treat onychomycosis and associated tinea pedis; BB2312 used for the treatment of Acne diseases, …
  • Allscripts Healthcare Solutions, Inc.:企業のM&A・事業提携・投資動向
    Allscripts Healthcare Solutions, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Allscripts Healthcare Solutions, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed report …
  • Mitsubishi Chemical Holdings Corporation:企業の戦略・SWOT・財務分析
    Mitsubishi Chemical Holdings Corporation - Strategy, SWOT and Corporate Finance Report Summary Mitsubishi Chemical Holdings Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Sumitomo Mitsui Trust Holdings Inc:企業の戦略・SWOT・財務情報
    Sumitomo Mitsui Trust Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Mitsui Trust Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Liberty Petroleum Corp:石油・ガス:M&Aディール及び事業提携情報
    Summary Liberty Petroleum Corp (Liberty) is an independent energy company that explores and develops oil and natural gas reserves. The company provides petroleum exploration properties such as onshore Cooper Eromanga Basin, offshore Gippsland Basin and offshore Browse Basin, among others. It holds p …
  • Uni-President Enterprises Corp:企業の戦略・SWOT・財務情報
    Uni-President Enterprises Corp - Strategy, SWOT and Corporate Finance Report Summary Uni-President Enterprises Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Harbin Gloria Pharmaceuticals Co Ltd (002437)-製薬・医療分野:企業M&A・提携分析
    Summary Harbin Gloria Pharmaceuticals Co Ltd (Harbin Gloria) is a pharmaceutical company that produces and markets nutritional drugs. The company’s products comprise pharmaceutical drugs for treating nutrition disorders, cardiovascular diseases, cancer and musculoskeletal disorders. Its pipeline pro …
  • Tesla Energy Operations Inc:企業の戦略的SWOT分析
    Tesla Energy Operations Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆